These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8871006)

  • 1. Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate.
    Illidge TM; Hussey M; Godden CW
    Clin Oncol (R Coll Radiol); 1996; 8(4):257-8. PubMed ID: 8871006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.
    Culbert EC; Schfirin BS
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):789-91. PubMed ID: 17018504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term control of hypercalcaemia in an infant with williams-Beuren syndrome after a single infusion of biphosphonate (Pamidronate).
    Oliveri B; Mastaglia SR; Mautalen C; Gravano JC; Pardo Argerich L
    Acta Paediatr; 2004 Jul; 93(7):1002-3. PubMed ID: 15303821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal administration of aminopropylidene diphosphonate.
    Dunlop DJ; Soukop M; McEwan HP
    Ann Rheum Dis; 1990 Nov; 49(11):955. PubMed ID: 2256749
    [No Abstract]   [Full Text] [Related]  

  • 5. Pamidronate and hypercalcaemia of malignancy.
    Lancet; 1989 Sep; 2(8663):617-8. PubMed ID: 2570304
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of pamidronate in PTHrP associated hypercalcaemia in infancy.
    Buckmaster A; Rodda C; Cowell CT; Ogle G; Dorney S
    J Pediatr Endocrinol Metab; 1997; 10(3):301-4. PubMed ID: 9388823
    [No Abstract]   [Full Text] [Related]  

  • 7. Immobilization hypercalcaemia responding to intravenous pamidronate sodium therapy.
    McIntyre HD; Cameron DP; Urquhart SM; Davies WE
    Postgrad Med J; 1989 Apr; 65(762):244-6. PubMed ID: 2594602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer.
    Coleman RE; Rubens RD
    Br J Cancer; 1987 Oct; 56(4):465-9. PubMed ID: 3689664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pamidronate (Aredia, Ciba) in malignant hypercalcaemia.
    MacConnachie AM
    Intensive Crit Care Nurs; 1997 Feb; 13(1):58-9. PubMed ID: 9095884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia.
    Sims EC; Rogers PB; Besser GM; Plowman PN
    Clin Oncol (R Coll Radiol); 1998; 10(6):407-9. PubMed ID: 9890546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D intoxication and hypercalcaemia in an infant treated with pamidronate infusions.
    Ezgu FS; Buyan N; Gündüz M; Tümer L; Okur I; Hasanoglu A
    Eur J Pediatr; 2004 Mar; 163(3):163-5. PubMed ID: 14714183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated cytokine levels in a patient with AIDS and hypercalcemia: effects of therapy with pamidronate.
    Carbone LD; Land MA; Stentz FB; Palmieri GM
    Clin Infect Dis; 1995 Sep; 21(3):699. PubMed ID: 8527580
    [No Abstract]   [Full Text] [Related]  

  • 14. Infusion rate and pharmacokinetics of intravenous pamidronate in the treatment of tumour-induced hypercalcaemia.
    Dodwell DJ; Howell A; Morton AR; Daley-Yates PT; Hoggarth CR
    Postgrad Med J; 1992 Jun; 68(800):434-9. PubMed ID: 1437922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal frequency of administration of pamidronate in patients with hypercalcaemia of malignancy.
    Wimalawansa SJ
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):591-5. PubMed ID: 7828347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypercalcemia of malignancy with intermittent single infusions of 3-amino-1-hydroxypropylidene-1, 1-biphosphonate (APD).
    Rischin D; Bishop JF
    Aust N Z J Med; 1988 Aug; 18(5):736-7. PubMed ID: 3245828
    [No Abstract]   [Full Text] [Related]  

  • 17. An audit of the management of malignant hypercalcaemia.
    Gerrard GE; Dodwell DJ; Vail A; Watters J; Overend MA
    Clin Oncol (R Coll Radiol); 1996; 8(1):39-42. PubMed ID: 8688360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcaemia in osteogenesis imperfecta treated with pamidronate.
    Williams CJ; Smith RA; Ball RJ; Wilkinson H
    Arch Dis Child; 1997 Feb; 76(2):169-70. PubMed ID: 9068314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
    Purohit OP; Radstone CR; Anthony C; Kanis JA; Coleman RE
    Br J Cancer; 1995 Nov; 72(5):1289-93. PubMed ID: 7577484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal phosphate threshold and response to pamidronate in humoral hypercalcaemia of malignancy.
    Gurney H; Kefford R; Stuart-Harris R
    Lancet; 1989 Jul; 2(8657):241-4. PubMed ID: 2569054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.